VRACY

Viralytics Ltd.

 
Sponsored ADR (1 ADS : 3 Ordinary) International Reporting
OTCQX International
Verified Company Profile 12/12/2016
Contact Info
  • Suite 305, Level 3
  • 66 Hunter Street
  • Sydney, NSW 2000
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Dec 31, 2016 Quarterly Report
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Queensland, Australia
Year of Inc. 1986
Employees 7 a/o Dec 11, 2016
Company Officers/Contacts
Malcolm McColl CEO, Managing Director
Robert Vickery CFO
Sarah Prince Secretary
Darren Shafren Chief Scientific Officer
Jennifer Dinneen Accountant
Company Directors
Paul Hopper Chairman, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Leonard Post Non-Executive Director, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Peter Turvey Non-Executive Director
Service Providers
Accounting/Auditing Firm
Grant Thornton Audit Pty Ltd
Level 17
383 Kent Street
Sydney, NSW, 2000
Australia
 
Securities Counsel
McCullough Robertson Lawyers
Level 11 Central Plaza Two, 66 Eagle Street
Brisbane, QL, 4000
Australia
 
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Roth Capital Partners, LLC on 08/05/2013.
  • Formerly=Psiron Ltd. until 1-07
VRACY Security Details Other Company Securities
Share Structure
Market Value1 $192,232,335 a/o Mar 22, 2017
Authorized Shares 240,290,419 a/o Dec 11, 2016
Outstanding Shares 240,290,419 a/o Dec 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
VLA - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security